688266.SH
泽璟制药-U
SSE · Healthcare · Biotechnology · CN
CNY 117.83
−8.45%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 53.75x
- P/E 2027E
- 83.56x
- P/E 2028E
- 62.69x
- P/S forward
- 95.00x
Trailing multiples
Trailing twelve months
- P/E TTM
- -191.42x
- PEG TTM
- —
- Price / book
- 18.13x
- Price / sales
- 20.17x
- Price / cash flow
- 38.33x
Enterprise value
- Enterprise value
- —
- EV / sales
- —
- EV / EBITDA
- —
- EV / EBIT
- —
- Market cap
- CNY 31.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026